Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Myeloid, Acute 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 64Myelodysplastic Syndromes 62Hodgkin Disease 57Leukemia 56Leukemia, Lymphocytic, Chronic, B-Cell 55Multiple Myeloma 51Lymphoma, Non-Hodgkin 48Lymphoma 44Myeloproliferative Disorders 37Graft vs Host Disease 37Lymphoma, Follicular 36Congenital Abnormalities 36Lymphoma, Large B-Cell, Diffuse 35Leukemia, Myeloid, Accelerated Phase 35Lymphoma, Mantle-Cell 34Lymphoma, B-Cell, Marginal Zone 31Leukemia, Myeloid, Chronic-Phase 31Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29Hematologic Neoplasms 29Burkitt Lymphoma 28Leukemia, Myelomonocytic, Chronic 27Blast Crisis 27Primary Myelofibrosis 26Neoplasms, Plasma Cell 25Lymphoma, Large-Cell, Immunoblastic 25Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 18Waldenstrom Macroglobulinemia 17Lymphoma, T-Cell, Cutaneous 16Anemia, Refractory, with Excess of Blasts 16

Interventions

Exercise 3Exercise Therapy 2Compression Bandages 2tapasin 1Tacrolimus 1Surveys and Questionnaires 1Resistance Training 1Ointments 1Muscle Stretching Exercises 1Low-Level Light Therapy 1House Calls 1Gloves, Protective 1Diagnosis-Related Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Breast Cancer Lymphedema × Tacrolimus × Clear all
NCT04541290 2022-02-09

Tacrolimus as Treatment of Breast Cancer-Related Lymphedema

Odense University Hospital

Phase 1/2 Completed
20 enrolled
Breast

Breast Cancer Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡